Default company panoramic image
Eternogen 20aesthetics 20logo 20v2

EternoGen Aesthetics, LLC

EternoGen is a clinical stage Medical Device company that has a transformative pipeline of liquid Collagen tissue products for the Aesthetic Medicine market.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded May 2009
  • Employees 10
  • Incorporation Type LLC
  • Website eternogen.com

Company Summary

EternoGen Aesthetics, LLC is a clinical stage Medical Device company that has developed a transformative pipeline of first-in-class liquid Collagen tissue products to restore lost dermal collagen, naturally reinforcing skin to provide long-term health & radiance. EternoGen is led by a group of proven industry veterans with strong industry connections needed for a successful commercialization into the aesthetic medicine market.

Team

  • Default avatar
    Anna Lundvall, MBA
    Chief Executive Officer and Chairman

    Anna has a proven record of success with over 20 years of senior management experience in the medical aesthetic industry. She is recognized as a visionary with her latest success being Evolence, the product that most closely resembles EternoGen's proposition. She played a key role in commercializing Evolence and securing an exit. Mrs. Lundvall has a tremendous rapport with industry-leading physicians and market leading firms.

  • Default avatar
    Luis Jimenez, MBA
    President and Chief Operations Officer

    Luis's experience includes operations, quality control in cGMP manufacturing, regulatory affairs for manufacturing, design engineering, technology transfer and project management. Mr. Jimenez’s background includes Chemical Engineering, Cum Laude and a Masters of Business Administration with Academic Excellence.

  • Default avatar
    Dale Devore, PhD
    Chief Scientific Officer

    Dr. DeVore is a leading commercialization scientific expert in collagen dermal filler products. His experience in dermal fillers includes: founding Autologen, VP of RD for Radiesse (in FDA panel meetings), and Sculptra. Dale brings over 35 years in clinical development and R&D. He has authored over 15 patents in dermal filler innovations. He excels in expertise and experience of formulations, troubleshooting issues and solving complex issues.

  • Default avatar
    Sheila Grant, PhD
    Chief Technology Officer

    Dr. Grant is a founder and expert technological platform manager. She is an expert in synthetic and organic tissue engineering at the University of Missouri. Her specific research interests involve developing nanostructured biocomposites. Her work addresses in-vivo analysis of tissue integration into novel biocomposites for soft tissue replacement as well as materials characterization of explanted biomaterials.

  • Default avatar
    Dave Grant, MSE
    Dir of Analytical Development

    Mr. Grant is a founder of EternoGen and expert material characterization manager. He has over 12 years of biomaterials research involvement including developing bio-nanocomposite materials utilizing metallic nanoparticles conjugated to acellular tissue or type I collagen. His work is inclusive of several patent applications, he specializes on physio and biological characterization of biomaterials.

  • Default avatar
    Rebecca Rone, MSE
    Dir of Clinical and Reg Dev

    She received her Masters of Science Degree in Bioengineering from the University of California-San Diego with a research focus in cartilage tissue engineering. While in graduate school, Ms. Rone gained experience at BREG as a design engineer for orthopaedic, reconstructive, and postoperative medical devices. She is a co-inventor of the EternoGen’s technology. She was also Associate Director and later Director of the Coulter Translational Partners

  • Default avatar
    Robert Brooks
    Dir of Quality

    He has more than 25 years of combined research and development experience ranging from academic research to drug development. . He has worked for CMOs and CROs that specialise in both clinical and chemical research, and much of his experience has been in cGMP and GLP environments. In addition he has over 10 years of experience in laboratory supervision and management, including QC management experience, and method development management.

  • Default avatar
    Charles Weatherstone
    Cheif Commercialization Officer

    He is a specialist in medical aesthetic marketing, having been responsible for the development, launch and management of a number of market leading brands including JUVEDERM ULTRA, BOTOX, and RESTYLANE. Charles has almost 20 years experience in blue chip and start-up health care marketing covering both medical device and pharmaceutical sectors.

Advisors

  • Default avatar
    Joe Soraghan principal at Danna McKitrick, PC (St. Louis)
    Lawyer
    Unconfirmed
    Default avatar
    John Weaver at Williams Keppers, LLC (Columbia, MO)
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Centennial Investors
    Unconfirmed
    Default avatar
    Missouri Technology Corporation
    Unconfirmed
    Default avatar
    Enterprise Investment Prorgam
    Unconfirmed